Outset Medical Ownership | Who Owns Outset Medical?
Outset Medical Ownership Summary
Outset Medical is owned by 0.05% institutional investors, 0.83% insiders, and 99.13% retail investors. Morgan stanley is the largest institutional shareholder, holding 7.50% of OM shares. Fidelity Select Health Care is the top mutual fund, with 7.52% of its assets in Outset Medical shares.
OM Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Outset Medical | 0.05% | 0.83% | 99.13% |
| Sector | Healthcare Stocks | 279.18% | 10.62% | -189.80% |
| Industry | Medical Device Stocks | 32.66% | 10.50% | 56.84% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Morgan stanley | 3.82M | 7.50% | $14.69M |
| Acadian asset management | 1.01M | 1.99% | $1.11M |
| Blackrock | 880.46K | 1.73% | $3.39M |
| Renaissance | 686.75K | 1.36% | $762.29K |
| Bank of new york mellon | 495.38K | 0.97% | $1.91M |
| Norges bank | 461.40K | 0.91% | $1.78M |
| Jacobs levy equity management | 396.21K | 0.78% | $1.53M |
| Charles schwab investment management | 295.22K | 0.58% | $1.14M |
| State street | 210.17K | 0.41% | $809.17K |
| Cubist systematic strategies | 200.94K | 0.39% | $773.62K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Birchview capital, lp | 24.58K | 0.24% | $271.90K |
| Ctc alternative strategies | 24.47K | 0.04% | $94.22K |
| Jacobs levy equity management | 396.21K | 0.01% | $1.53M |
| Cubist systematic strategies | 200.94K | 0.01% | $773.62K |
| Acadian asset management | 1.01M | 0.00% | $1.11M |
| Morgan stanley | 3.82M | 0.00% | $14.69M |
| Renaissance | 686.75K | 0.00% | $762.29K |
| Aqr capital management | 142.43K | 0.00% | $548.36K |
| Huntington national bank | 57.31K | 0.00% | $63.61K |
| Fintrust capital advisors | 620.00 | 0.00% | $2.39K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Renaissance | 686.75K | 0.00% | 632.57K |
| Norges bank | 461.40K | 0.00% | 461.40K |
| Cubist systematic strategies | 200.94K | 0.01% | 139.74K |
| Susquehanna group, llp | 92.94K | - | 65.46K |
| Ctc alternative strategies | 24.47K | 0.04% | 24.47K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | - | - | -3.67M |
| Vanguard group | - | - | -2.61M |
| Blackrock | 880.46K | 0.00% | -2.39M |
| Ameriprise financial | - | - | -1.81M |
| Massachusetts financial services co /ma/ | - | - | -1.54M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 461.40K | 0.00% | 461.40K | $1.78M |
| Ctc alternative strategies | 24.47K | 0.04% | 24.47K | $94.22K |
| Wolverine trading | 11.06K | - | 11.06K | $42.60K |
| Macquarie group | 2.52K | - | 2.52K | $9.72K |
Sold Out
| Holder | Change |
|---|---|
| Ronald blue trust | -4.00 |
| Cranbrook wealth management | -6.00 |
| Wells fargo & company/mn | -11.00 |
| First command advisory services | -12.00 |
| Quantbot technologies lp | -23.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 1 | -98.72% | 24,584 | -99.88% | - | 0.00% | - | -100.00% | 1 | -95.83% |
| Dec 31, 2024 | 31 | -62.20% | 7,241,955 | -72.21% | 14 | 0.54% | 11 | -54.17% | 9 | -74.29% |
| Sep 30, 2024 | 81 | -33.06% | 26,057,063 | -46.36% | 51 | 0.57% | 25 | -59.68% | 35 | -7.89% |
| Jun 30, 2024 | 121 | 6.14% | 48,575,467 | -2.94% | 95 | 0.96% | 62 | 31.91% | 38 | -5.00% |
| Mar 31, 2024 | 114 | -18.57% | 50,046,537 | -5.21% | 99 | 0.89% | 47 | -31.88% | 40 | -9.09% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Select Health Care | 1.33M | 7.52% | 1.33M |
| Fidelity Advisor Health Care I | 799.08K | 4.51% | 799.08K |
| T. Rowe Price US Small-Cap Core Equity | 719.35K | 4.06% | 719.35K |
| T. Rowe Price Small-Cap Stock | 719.35K | 4.06% | 719.35K |
| MFS New Discovery I | 547.03K | 3.09% | 547.03K |
| MEDICAL BioHealth EUR Acc | 1.54M | 2.95% | 1.54M |
| T. Rowe Price Instl Small-Cap Stock | 382.05K | 2.16% | 382.05K |
| Fidelity Growth Compy Commingled Pl O | 1.05M | 2.01% | -769.40K |
| T. Rowe Price U.S. SC Core Eq Tr-Z | 336.75K | 1.90% | 336.75K |
| T. Rowe Price U.S. SC Core Eq Tr-D | 336.75K | 1.90% | 336.75K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 15, 2025 | Trigg Leslie | Chair and CEO | Sell | $16.64K |
| May 15, 2025 | Nash Marc | SVP Operations and R&D | Sell | $4.49K |
| May 15, 2025 | Brottem John L. | General Counsel | Sell | $7.06K |
| May 15, 2025 | Ahmed Nabeel | Chief Financial Officer | Sell | $10.40K |
| Feb 18, 2025 | Trigg Leslie | Chair and CEO | Sell | $13.15K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | 4 |
| 2025 Q1 | - | 25 |
| 2024 Q4 | - | 4 |
| 2024 Q3 | - | 5 |
| 2024 Q2 | - | 8 |
OM Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools